Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized …
NM Bressler, SB Bressler… - … (Chicago, Ill.: 1960 …, 2005 - pubmed.ncbi.nlm.nih.gov
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular
degeneration: four-year results of an open-label extension of 2 randomized clinical trials:
TAP Report No. 7 Verteporfin therapy for subfoveal choroidal neovascularization in age-related
macular degeneration: four-year results of an open-label extension of 2 randomized clinical
trials: TAP Report No. 7 Arch Ophthalmol. 2005 Sep;123(9):1283-5. doi: 10.1001/archopht.123.9.1283.
Authors Neil M Bressler, Susan B Bressler, Laurie A Haynes, Yong Hao, Peter K Kaiser …
degeneration: four-year results of an open-label extension of 2 randomized clinical trials:
TAP Report No. 7 Verteporfin therapy for subfoveal choroidal neovascularization in age-related
macular degeneration: four-year results of an open-label extension of 2 randomized clinical
trials: TAP Report No. 7 Arch Ophthalmol. 2005 Sep;123(9):1283-5. doi: 10.1001/archopht.123.9.1283.
Authors Neil M Bressler, Susan B Bressler, Laurie A Haynes, Yong Hao, Peter K Kaiser …
